Mitochondrial myopathies: divergences of genetic deletions, biochemical defects and the clinical syndromes

J Neurol. 1990 Feb;237(1):5-10. doi: 10.1007/BF00319660.

Abstract

Genomic Southern analysis of muscle mitochondrial (mt) DNA from 16 patients with mitochondrial myopathies was performed; 14 of 16 patients had chronic progressive external ophthalmoplegia (CPEO), while 2 patients had mitochondrial myopathies without CPEO. Eleven patients with CPEO, including 5 who exhibited the complete triad of symptoms characteristic of the Kearns-Sayre syndrome (i.e. CPEO, retinal degeneration and heart block) had heteroplasmic mtDNA with deletions ranging from 2.0 to 8.0 kb in length. There was no clear-cut correlation between the size and location of the deletions, on the one hand, and the histochemical and biochemical data or the severity of the disease, on the other.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Blotting, Southern
  • Child
  • Chromosome Deletion*
  • Chronic Disease
  • Cytochrome-c Oxidase Deficiency
  • DNA Probes
  • DNA, Mitochondrial / genetics*
  • Histocytochemistry
  • Humans
  • Kearns-Sayre Syndrome / enzymology
  • Kearns-Sayre Syndrome / genetics*
  • Middle Aged
  • Mitochondria, Muscle / enzymology*
  • Mitochondria, Muscle / pathology
  • Muscular Diseases / enzymology
  • Muscular Diseases / genetics*
  • Ophthalmoplegia / genetics*

Substances

  • DNA Probes
  • DNA, Mitochondrial